[EN] HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE [FR] TRIAZOLES SUBSTITUÉS PAR HÉTÉROCYCLYLAMINO UTILISÉS EN TANT QUE MODULATEURS DE LA PROTÉINE KINASE ASSOCIÉE À RHO
[EN] HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE [FR] TRIAZOLES SUBSTITUÉS PAR HÉTÉROCYCLYLAMINO UTILISÉS EN TANT QUE MODULATEURS DE LA PROTÉINE KINASE ASSOCIÉE À RHO
HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
申请人:Redx Pharma Plc
公开号:EP3743420A1
公开(公告)日:2020-12-02
Modulators of Rho-associated Protein Kinase
申请人:RedX Pharma PLC
公开号:US20210038606A1
公开(公告)日:2021-02-11
This invention relates to novel compounds and pharmaceutical compositions comprising the same. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.